Literature DB >> 9024569

Giant-cell chondrodysplasia in a male infant with clinical and radiological findings resembling the Piepkorn type of lethal osteochondrodysplasia.

M Urioste1, J I Rodríguez, J M Bofarull, N Torán, C Ferrer, A Villa.   

Abstract

We report on a patient whose clinical, radiologic, and histopathologic findings are compatible with the Piepkorn type of lethal short-limb osteochondrodysplasia, but who also showed multinucleated giant chondrocytes in cartilage. Multinucleated giant cells are an unusual finding in osteochondrodysplasias, having been reported in atelosteogenesis type I and boomerang dysplasia. This uncommon histopathologic finding and the clinical and radiographic findings strongly support the diagnosis of boomerang dysplasia in the present patient. Our patient supports the previously suggested existence of an entity including atelosteogenesis and boomerang dysplasia. If this is so, the current patient and that described by Piepkorn et al. [1977: Teratology 16:345-350] could represent the most severe clinical expression of that condition.

Entities:  

Mesh:

Year:  1997        PMID: 9024569

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  2 in total

1.  Comparative analysis of the two extremes of FLNB-mutated autosomal dominant disease spectrum: from clinical phenotypes to cellular and molecular findings.

Authors:  Qiming Xu; Nan Wu; Lijia Cui; Mao Lin; D Thirumal Kumar; C George Priya Doss; Zhihong Wu; Jianxiong Shen; Xiangjian Song; Guixing Qiu
Journal:  Am J Transl Res       Date:  2018-05-15       Impact factor: 4.060

2.  Piepkorn type of osteochondrodysplasia: Defining the severe end of FLNB-related skeletal disorders in three fetuses and a 106-year-old exhibit.

Authors:  Helga Rehder; Franco Laccone; Susanne G Kircher; Ralf L Schild; Christiane Rapp; Rainer Bald; Bernt Schulze; Jana Behunova; Juergen Neesen; Katharina Schoner
Journal:  Am J Med Genet A       Date:  2018-05-23       Impact factor: 2.802

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.